Related Experiment Video
Updated: Aug 3, 2025

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
GCCN: Graph Capsule Convolutional Network for Progressive Mild Cognitive Impairment Prediction and Pathogenesis
Abstract:
In this study, we proposed a novel method called the graph capsule convolutional network (GCCN) to predict the progression from mild cognitive impairment to dementia and identify its pathogenesis. First, we proposed a novel risk gene discovery component to indirectly target genes with higher interactions with others. These risk genes and brain regions were collected as nodes to construct heterogeneous pathogenic information association graphs. Second, the graph capsules were established by projecting heterogeneous pathogenic information into a set of disentangled latent components. The orientation and length of capsules are representations of the format and intensity of pathogenic information. Third, graph capsule convolution network was used to model the information flows among pathogenic factors and elaborates the convergence of primary capsules to advanced capsules. The advanced capsule is a concept that organizes pathogenic information based on its consistency, and the synergistic effects of advanced capsules directed the development of the disease. Finally, discriminative pathogenic information flows were captured by a straightforward built-in interpretation mechanism, i.e., the dynamic routing mechanism, and applied to the identification of pathogenesis. GCCN has been experimentally shown to be significantly advanced on public datasets. Further experiments have shown that the pathogenic factors identified by GCCN are evidential and closely related to progressive mild cognitive impairment.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Prosopagnosia
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Alzheimer's Disease: Treatment

